This is a Phase 1 Study of MH048 in Patients With Selected Relapsed/Refractory B-cell Malignancies
Clinical trial NCT04689308 · UNKNOWN
Trial details
- NCT number
- NCT04689308
- Sponsor
- Minghui Pharmaceutical (Shanghai) LTD
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-07
- Primary completion
- 2023-06-30
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.